Bristol-Myers Squibb Co. Equity-NMS: BMY

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$56.62
Open :	$56.46
Today's high :	$56.56
Today's low :	$55.1
52W low :	$41.8826
52W high :	$60.2846
1Y :	-1.94%
5Y :	-15.78%
EPS(TTM): :	2.97
Shares O/S :	2.04 B
Market cap :	112.5 B

What is the share price of Bristol-Myers Squibb Co. today?

Bristol-Myers Squibb Co. (BMY) share price as of January 18, 2026, is $55.26. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Bristol-Myers Squibb Co.?

Yes, Indian Investors can invest in the Bristol-Myers Squibb Co. (BMY) Share by opening an international trading account with Angel One.

How can I purchase Bristol-Myers Squibb Co. shares in India?

Purchasing Bristol-Myers Squibb Co. (BMY) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Bristol-Myers Squibb Co. (BMY) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Bristol-Myers Squibb Co.?

Yes, you can purchase fractional shares of Bristol-Myers Squibb Co. (BMY) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Bristol-Myers Squibb Co.?

The market capitalization of Bristol-Myers Squibb Co. on January 18, 2026, is $112.5 B.

In which sector Bristol-Myers Squibb Co. belongs?

Bristol-Myers Squibb Co. operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

What documents are required to invest in Bristol-Myers Squibb Co. stocks?

In order to invest in Bristol-Myers Squibb Co. (BMY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.